The Nebraska Medical Association

https://www.nebmed.org/

 

The Nebraska Medical Association
T

Mediators of Cardiovascular Risk Reduction With MTX Use in Rheumatoid Arthritis

By The Nebraska Medical Association FEATURING Tate Johnson
By The Nebraska Medical Association FEATURING Tate Johnson
0 views
June 21, 2022
Comments 0
Login to view comments. Click here to Login

Featured Video

08:18
Insights from 2023 ASH Annual Meeting

Treatment Strategies for Hematocrit Control in PV

Feat. A. Zhou

Featured Video

24:35
Indy Hematology Review

Current Approaches in the Treatment of Myeloproliferative Neoplasms

Feat. A. Tefferi
Nebraska Rheumatology Society
69:57
The Nebraska Medical Association

SARS-CoV-2 Vaccination in Autoimmune Diseases: Updates on Immunogeni…

Feat. A. Kim
24:00
The Nebraska Medical Association

Updates on Gout: Epidemiology, Cause-Specific Mortality, & Medic…

Feat. L. Helget
16:47
The Nebraska Medical Association

Nebraska Medical Association Legislative Update 2022

Feat. D. Schrodt
11:48
The Nebraska Medical Association

Nebraska Medical Association Legislative Update 2021

Feat. D. Schrodt
13:13
The Nebraska Medical Association

Mediators of Cardiovascular Risk Reduction With MTX Use in Rheumatoi…

Feat. T. Johnson
12:37
The Nebraska Medical Association

Nebraska Rheumatology Society COVID-19 Update 2021: Vaccination

Feat. T. Mikuls
26:20
Nebraska Rheumatology Society

2020 Update on Behcet's Syndrome: What Are ISG Criteria of Cond…

Feat. Y. Yazici
12:06
Nebraska Rheumatology Society

Behcet's Syndrome 2020 Update: What Is the Efficacy of TNF Anto…

Feat. Y. Yazici